• Biotech's IPO Breakdown

    Aug 14, 2013, 08:00 AM by Michael Croft
    Forbes | It's been a banner year for biotech IPOs--27 have gone public since January. Forbes breaks down who, when, and how much.
    Full story
  • Bind Therapeutics Announces IPO

    Aug 13, 2013, 09:00 AM by Michael Croft
    Boston Globe | Bind Therapeutics filed an IPO registration yesterday, planning to raise $80.5 million. The company said it has already raised $94.7 million.
    Full story
  • Perakslis Joins Precision for Medicine

    Aug 13, 2013, 08:00 AM by Michael Croft
    Bio-IT World News Brief | Eric Perakslis has joined Precision for Medicine, Inc. as Senior Advisor, Bioinformatics and Information Technology. Precision is a specialized scientific services company formed in 2012 to support next generation medical products. The company is headquartered in Bethesda, Md with offices in Frederick, Md and Cambridge, Mass.
    Full story
  • Nimbus Offers All-Flash Systems with 1x Nanometer Flash

    Aug 12, 2013, 12:00 PM by Michael Croft
    Bio-IT World | Nimbus Data Systems has announced its fourth-generation all-flash arrays: the Gemini F400 and F600. Thomas Isakovich, CEO of Nimbus Data, tells Bio-IT World that the new offerings will mark a tide change in how widely flash is used, especially in technical computing sectors like the life sciences.
    Full story
  • GenoSpace, PathGroup, Thomson Reuters Launch Oncology Personalized Medicine Service

    Aug 12, 2013, 10:00 AM by Michael Croft
    Bio-IT World News Brief | GenoSpace, PathGroup and Thomson Reuters have launched an initiative to develop and deliver a best-in-class personalized medicine service for oncology.
    Full story
  • Big Data at the NIH

    Aug 12, 2013, 08:00 AM by Michael Croft
    CTOvision | Mark Guyer, deputy director of the NIH’s National Human Genome Research Institute (NHGRI), speaks with CTOvision about the big data centers of excellence, and the trends in data sharing.
    Full story
  • The Cost of Drugs Today

    Aug 12, 2013, 08:00 AM by Michael Croft
    Forbes | A Forbes analysis finds that a company hoping to get a single drug to market can expect to have spent $350 million before the medicine is available for sale.
    Full story
  • Predicting Preterm Birth

    Aug 12, 2013, 08:00 AM by Michael Croft
    The Scientist | GNS Healthcare and Inova Translational Medicine Institute are collaborating to predict preterm birth. Using GNS's big data analytics platform and Invoa medical records, the groups hope to identify biomarkers that could predict early births.
    Full story
  • Gene By Gene to Acquire Arpeggi

    Aug 8, 2013, 02:00 AM by Michael Croft
    Bio-IT World | Arpeggi announced yesterday its impending acquisition by Gene By Gene, a Houston-based consumer genomics company that develops products for ancestry and genealogy applications. The new company hopes to make available an innovative suite of more affordable genetics testing and diagnostics services to consumers, researchers and healthcare providers.
    Full story
  • The Henrietta Compromise: NIH Announces HeLa Data Use Agreement

    Aug 7, 2013, 12:00 PM by Michael Croft
    Bio-IT World | The National Institutes of Health announced this morning that it has reached an “understanding” with the family of Henrietta Lacks to allow controlled access to whole genome sequence data from HeLa cells, the cells derived without consent from the tumor of Henrietta Lacks in 1951.
    Full story
  • Fast Science: Real Time Genomics Moves to Mendelian Diseases

    Aug 7, 2013, 04:00 AM by Michael Croft
    Bio-IT World | Real Time Genomics chose cows for their first proof of principle, but a lot has changed in the 18 months since I sat down in their Hamilton, New Zealand, offices and toured a dairy farmer’s cooperative down the road. Today RTG’s extremely fast genomics analytics platform is proving itself faster, cheaper and more efficient than the competition for tackling Mendelian genetics.
    Full story
  • 23andMe Launches TV Ads for DTC Genomics

    Aug 6, 2013, 11:00 AM by Michael Croft
    Bio-IT World News Brief | 23andMe has launched a television advertising campaign. Portraits of Health focuses on educating consumers about how understanding their DNA can help them make more informed and proactive health decisions, while building brand awareness for 23andMe.
    Full story
  • Combination Therapy Targets Breast Cancer that has Spread to Brain

    Aug 6, 2013, 10:00 AM by Michael Croft
    UCLA Newsroom | Using a mouse-model system, researchers at UCLA Jonsson Comprehensive Cancer Center have combined cellular therapy and gene therapy to develop a possible treatment for breast cancer that has spread to the brain.
    Full story
  • Kickstarting Cancer

    Aug 5, 2013, 10:00 AM by Michael Croft
    Forbes | What would crowd funding for cancer look like? A Forbes contributor suggests a Kickstarter campaign focusing on individuals with cancers that aren't responding to treatment or aren't well-characterized.
    Full story
  • Ceiba Launches Free Helium Analytical Workbench

    Aug 5, 2013, 08:00 AM by Michael Croft
    Bio-IT World News Brief | Ceiba has introduced a free version of its Helium Data Workbench that offers more than 50 analytical functions to bring public life science data directly into Microsoft Excel, TIBCO Spotfire and the Helium Windows 8 app.
    Full story
  • July News and Product Briefs

    Aug 2, 2013, 09:00 AM by Michael Croft
    Bio-IT World | News briefs and products from around the industry including Illumina's acquisitions, new products for clinical sites and data virtualization, Comcast in health-IT, and more.
    Full story
  • Biopharma Cubist Makes Two Acquisitions for up to $1.6B

    Aug 2, 2013, 07:00 AM by Michael Croft
    Bio-IT World News Brief |Cubist Pharmaceuticals, a Lexington, Mass.-based biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment has signed two merger agreements, with Trius Therapeutics and Optimer Pharmaceuticals. The combined total of the two acquisitions could $1.6 billion.
    Full story
  • Foundation Medicine's IPO Prospects

    Aug 1, 2013, 08:00 AM by Michael Croft
    Boston Globe | Foundation Medicine filed plans this week to raise $86.25 million in an IPO, and the Boston Globe posits it could be aiming too low.
    Full story
  • An Expert's Overview: the Genomics of Genius, Alzheimer's, and the Future of Hospitals

    Jul 31, 2013, 15:00 PM by Michael Croft
    Medspace | Eric Topol weighs in on what he's seen interesting on the Web lately including the genomics of genius, Alzheimer's Disease, and the obsolete future of the hospital room
    Full story
  • NVIDIA Acquires The Portland Group

    Jul 30, 2013, 07:00 AM by Michael Croft
    Bio-IT World News Brief | NVIDIA has acquired The Portland Group (PGI), a supplier of tools and compilers for high performance computing. "PGI and its exceptionally talented staff will continue to operate under the PGI flag – developing OpenACC, CUDA Fortran and CUDA x86 for multicore x86 and, of course, GPGPUs," NVIDIA said on its blog.
    Full story